Twist Bioscience chooses Imagene’s DNAshell® technology

Twist Bioscience Enhances DNA Storage Capabilities Through Agreement With Imagene SA
— Agreement Enables Twist to Securely Store DNA With Digital Data Encoded —
SAN FRANCISCO–(BUSINESS WIRE)–Jul. 25, 2019– Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it has entered into an …Read More

kit Ciq bcr ab1

Imagene and GBMHM optimize molecular analyses

Evry, France, 15th January, 2014
Imagene and the Group of Molecular Biologists for Hematological Malignancies (GBMHM) have signed a partnership agreement. The goal is to use Imagene’s technology to produce, store and distribute the standards needed for molecular analysis of patients with leukemia and other blood cancers. 
Download the press release (in French)